NASDAQ: PAGP

PLAINS GP HOLDINGS LP

CIK 0001581990 · SIC 4610 · Pipelines (Except Natural Gas)

Mega Revenue $44.3B Assets $30.2B as of Aug 16, 2026

Every 8-K is open in full. Other 10-Ks and 10-Qs show a 3-bullet preview. A free account reads 3 more full reports a month. Generating a report requires a verified account.

Sign up free

Want to see a complete report first? Today's free report (HPQ 10-Q) is open in full — no account needed.

10-Q Filed Aug 10, 2026 · Period ending Jun 30, 2026 Red flag

Plains GP Q2 2026: Net income surges 1196.7% to $389.0M on Canadian NGL sale gain

3 material changes detected. Sign up free to read the summary.

8-K Filed Aug 7, 2026 · Period ending Aug 7, 2026

Summary not yet generated.

Partner

Trade PAGP commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

8-K Filed Jun 17, 2026 · Period ending Jun 12, 2026

Plains GP refinances credit facilities with new $2.7B unsecured revolver, extends maturity to 2031

4 material changes detected. Sign up free to read the summary.

8-K Filed Jun 2, 2026 · Period ending Jun 1, 2026

Plains GP Holdings announces Chief Accounting Officer succession as Herbold retires

2 material changes detected. Sign up free to read the summary.

8-K Filed May 22, 2026 · Period ending May 20, 2026 Red flag

PAGP shareholders signal concern over executive pay with 35.6% opposition vote

3 material changes detected. Sign up free to read the summary.

8-K Filed May 13, 2026 · Period ending May 11, 2026

Plains GP Holdings appoints former Oil States CEO Cynthia Taylor to board

3 material changes detected. Sign up free to read the summary.

8-K Filed May 12, 2026 · Period ending May 12, 2026

Plains GP completes $3.76B sale of Canadian NGL business, to pay down $3.3B in debt

5 material changes detected. Sign up free to read the summary.

10-Q Filed May 8, 2026 · Period ending Mar 31, 2026

revenue $12.5B, net income $20.0M. Plains GP net income falls 76.2% as Canadian NGL sale nears; distribution up 10% to /year

5 material changes detected. Sign up free to read the summary.

8-K Filed May 8, 2026 · Period ending May 8, 2026

Plains GP Holdings reports Q1 2026 earnings results

2 material changes detected. Sign up free to read the summary.

10-K Filed Feb 27, 2026 · Period ending Dec 31, 2025

Summary not yet generated.

10-Q Filed Nov 7, 2025 · Period ending Sep 30, 2025

Summary not yet generated.

10-Q Filed Aug 8, 2025 · Period ending Jun 30, 2025

Summary not yet generated.

10-Q Filed May 9, 2025 · Period ending Mar 31, 2025

Summary not yet generated.

10-K Filed Feb 28, 2025 · Period ending Dec 31, 2024

Summary not yet generated.

Latest financial statements

From 10-Q filed Aug 10, 2026 (period ending Jun 30, 2026). As printed on the EDGAR/iXBRL face — not generated by the model.

As filed

Condensed Consolidated Statements of Operations

(in millions, except per share data)

Description Three months ended June 30, 2026 (unaudited) Three months ended June 30, 2025 (unaudited) Six months ended June 30, 2026 Six months ended June 30, 2025
REVENUES
Product sales revenues 17,221 10,197 29,246 21,243
Services revenues 472 445 916 876
Total revenues 17,693 10,642 30,162 22,119
COSTS AND EXPENSES
Purchases and related costs 16,556 9,758 28,049 20,277
Field operating costs 328 286 628 585
General and administrative expenses 111 84 195 171
Depreciation and amortization 242 235 486 466
Losses on asset sales, asset impairments and other, net 59 42 6 29
Total costs and expenses 17,296 10,405 29,364 21,528
OPERATING INCOME 397 237 798 591
OTHER INCOME/(EXPENSE)
Equity earnings in unconsolidated entities 89 94 178 196
Gain on investments in unconsolidated entities, net 31
Interest expense (net of capitalized interest of $2, $3, $3 and $5, respectively) (135) (110) (279) (217)
Other income, net 24 8 8 14
INCOME FROM CONTINUING OPERATIONS BEFORE TAX 375 229 705 615
Current income tax expense from continuing operations (107) (1) (322) (6)
Deferred income tax (expense)/benefit from continuing operations (102) (15) 106 (40)
INCOME FROM CONTINUING OPERATIONS, NET OF TAX 166 213 489 569
INCOME FROM DISCONTINUED OPERATIONS, NET OF TAX (NOTE 2) 1,649 70 1,548 206
NET INCOME 1,815 283 2,037 775
Net income attributable to noncontrolling interests from continuing operations (240) (203) (515) (513)
Net income attributable to noncontrolling interests from discontinued operations (1,186) (50) (1,114) (148)
Net income attributable to noncontrolling interests (1,426) (253) (1,629) (661)
Net income/(loss) attributable to PAGP from continuing operations (74) 10 (26) 56
Net income attributable to PAGP from discontinued operations 463 20 434 58
NET INCOME ATTRIBUTABLE TO PAGP 389 30 408 114
Basic weighted average Class A shared outstanding 198 198 198 198
Basic Net Income/(Loss) per Class A Share:
Continuing operations (0.37) 0.05 (0.13) 0.29
Discontinued operations 2.34 0.10 2.19 0.29
Basic Net Income per Class A Share 1.97 0.15 2.06 0.58
Diluted weighted average Class A shares outstanding 198 198 198 233
Diluted Net Income/(Loss) per Class A Share:
Continuing operations (0.37) 0.05 (0.13) 0.29
Discontinued operations 2.34 0.10 2.19 0.28
Diluted net income per Class A Share 1.97 0.15 2.06 0.57

Condensed Consolidated Balance Sheets (Unaudited)

(in millions, except share data)

Description June 30, 2026 (unaudited) December 31, 2025
ASSETS
CURRENT ASSETS
Cash and cash equivalents 1,060 329
Trade accounts receivable and other receivables, net 5,267 3,598
Inventory 84 211
Current assets of discontinued operations (Note 2) 479
Other current assets 119 87
Total current assets 6,530 4,704
PROPERTY AND EQUIPMENT 22,702 22,536
Accumulated depreciation (5,921) (5,676)
Property and equipment, net 16,781 16,860
OTHER ASSETS
Investments in unconsolidated entities 2,817 2,846
Intangible assets, net 1,610 1,754
Deferred tax asset 1,083 1,136
Linefill 892 900
Long-term operating lease right-of-use assets, net 172 198
Long-term inventory 257 214
Long-term assets of discontinued operations (Note 2) 2,557
Other long-term assets, net 91 107
Total assets 30,233 31,276
LIABILITIES AND PARTNERS’ CAPITAL
CURRENT LIABILITIES
Trade accounts payable 4,942 3,457
Short-term debt 9 563
Current liabilities of discontinued operations (Note 2) 154 382
Other current liabilities 746 500
Total current liabilities 5,851 4,902
LONG-TERM LIABILITIES
Senior notes, net 8,373 9,118
Other long-term debt, net 59 1,578
Long-term operating lease liabilities 194 202
Long-term liabilities of discontinued operations (Note 2) 606
Other long-term liabilities and deferred credits 442 654
Total long-term liabilities 9,068 12,158
COMMITMENTS AND CONTINGENCIES (NOTE 10)
PARTNERS’ CAPITAL
Class A shareholders (197,904,124 and 197,904,124 shares outstanding, respectively) 1,580 1,345
Noncontrolling interests 13,734 12,871
Total partners’ capital 15,314 14,216
Total liabilities and partners’ capital 30,233 31,276

Condensed Consolidated Statements of Cash Flows

(in millions)

Description Six months ended June 30, 2026 (unaudited) Six months ended June 30, 2025
CASH FLOWS FROM OPERATING ACTIVITIES
Net income 2,037 775
Reconciliation of net income to net cash provided by operating activities:
Income from discontinued operations, net of tax (1,548) (206)
Depreciation and amortization 486 466
Losses on asset sales, asset impairments and other, net 6 29
Deferred income tax expense/(benefit) (106) 40
(Gain)/loss on foreign currency revaluation (16) 4
Equity earnings in unconsolidated entities (178) (196)
Distributions on earnings from unconsolidated entities 204 256
Gain on investments in unconsolidated entities, net (31)
Other 27 32
Changes in assets and liabilities, net of acquisitions 299 (140)
Cash provided by operating activities continuing operations 1,211 1,029
Cash provided by operating activities discontinued operations 159 301
Net cash provided by operating activities 1,370 1,330
CASH FLOWS FROM INVESTING ACTIVITIES
Cash paid in connection with acquisitions, net of cash acquired (130) (681)
Additions to property, equipment and other (268) (310)
Cash paid for purchases of linefill (12) (17)
Proceeds from sales of assets 4 21
Cash received from sales of linefill 37
Other investing activities 20
Cash used in investing activities continuing operations (349) (987)
Cash provided by/(used in) investing activities discontinued operations 3,451 (106)
Net cash provided by/(used in) investing activities 3,102 (1,093)
CASH FLOWS FROM FINANCING ACTIVITIES
Net borrowings/(repayments) under PAA commercial paper program (Note 6) (970) 69
Repayment under PAA term loan (Note 6) (1,100)
Proceeds from the issuance of PAA senior notes (Note 6) 998
Repayments of PAA senior notes (Note 6) (750)
Repurchase of common units by a subsidiary (8)
Repurchase of Series A preferred units by a subsidiary (Note 7) (333)
Distributions paid to Class A shareholders (Note 7) (165) (150)
Distributions paid to noncontrolling interests (Note 7) (734) (731)
Contributions from noncontrolling interests 29
Other financing activities (6) (19)
Net cash provided by/(used in) financing activities (3,725) (145)
Effect of translation adjustment continuing operations (16) 8
Effect of translation adjustment discontinued operations 11
Net increase in cash and cash equivalents and restricted cash 731 111
Cash and cash equivalents and restricted cash, beginning of period 329 349
Cash and cash equivalents and restricted cash, end of period 1,060 460
Cash paid for:
Interest, net of amounts capitalized 259 216
Income taxes, net of amounts refunded 53 48

Amounts as printed on the EDGAR/iXBRL face — (in millions, except per share data); (in millions, except share data); (in millions). Labels, columns, and figures are the filing face, not a GAAP stencil. Interactive statements & notes on EDGAR ↗

View AI report for this filing